JAGUAR HEALTH, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Revenue | $4.4M | $141.5K | $258.4K | $0 |
| Cost of Revenue | $880.4K | $52.0K | $123.5K | — |
| Gross Profit | $3.5M | $89.6K | $134.9K | — |
| Gross Margin | 79.8% | 63.3% | 52.2% | — |
| Operating Expenses | ||||
| Research & Development | $4.3M | $7.2M | $6.5M | $4.2M |
| SG&A Expense | $11.2M | $6.0M | $5.3M | $4.1M |
| Operating Income | $-34.2M | $-13.6M | $-12.4M | $-8.3M |
| Operating Margin | -785.3% | -9,599.8% | -4,816.7% | — |
| Interest Expense | $1.2M | $985.5K | $3.3M | $345.3K |
| Pretax Income | $-35.1M | $-14.7M | — | — |
| Income Tax Expense | $-13.2M | — | — | — |
| Net Income | $-22.0M | $-14.7M | $-16.3M | $-8.6M |
| Net Margin | -503.7% | -10,410.9% | -6,305.2% | — |
| EPS (Basic) | $-0.03 | $0.00 | $-0.01 | $-0.01 |
| EPS (Diluted) | $-0.03 | $0.00 | $-0.01 | $-0.01 |
| Shares Outstanding (Basic) | 4.03B | 4.03B | 2.34B | 827.8M |
| Shares Outstanding (Diluted) | 4.03B | 4.03B | 2.34B | 827.8M |
| Dividends Per Share | — | — | — | — |